 TDOC has infamously recorded an immense asset impairment worth 9.63B over the LTM, likely attributed to the overly expensive Livongo acquisition worth 18.5B. With other players embarking on aggressive MA activities into the virtual and primary healthcare market, it remains to be seen if CVS will learn from its peer mistake. 